Log In
BCIQ
Print this Print this
 

Vi-CRM197

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionVaccine against typhoid fever
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPhase II
Standard IndicationTyphoid
Indication DetailsPrevent typhoid fever
Regulatory Designation
PartnerBiological E. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

07/15/2013

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today